$SBRA
Sabra Health Care REIT, Inc.

2011 Q2 Form 10-Q Financial Statement

#000149229811000004 Filed on August 03, 2011

View on sec.gov

Income Statement

Concept 2011 Q2
Revenue $18.81M
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.900M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.290M
YoY Change
% of Gross Profit
Operating Expenses $9.200M
YoY Change
Operating Profit
YoY Change
Interest Expense -$7.500M
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $2.100M
YoY Change
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $2.087M
YoY Change
Net Earnings / Revenue 11.1%
Basic Earnings Per Share $0.08
Diluted Earnings Per Share $0.08
COMMON SHARES
Basic Shares Outstanding 25.15M shares
Diluted Shares Outstanding 25.23M shares

Balance Sheet

Concept 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.500M
YoY Change
Cash & Equivalents $3.454M
Short-Term Investments
Other Short-Term Assets $17.90M
YoY Change
Inventory $542.6M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $564.0M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $31.80M
YoY Change
Total Long-Term Assets $31.80M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $564.0M
Total Long-Term Assets $31.80M
Total Assets $595.8M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.700M
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $35.00M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $384.9M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $384.9M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $35.00M
Total Long-Term Liabilities $384.9M
Total Liabilities $420.0M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $251.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $175.8M
YoY Change
Total Liabilities & Shareholders Equity $595.8M
YoY Change

Cashflow Statement

Concept 2011 Q2
OPERATING ACTIVITIES
Net Income $2.087M
YoY Change
Depreciation, Depletion And Amortization $6.290M
YoY Change
Cash From Operating Activities $5.400M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$74.00M
YoY Change
Cash From Investing Activities -$74.00M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.200M
YoY Change
NET CHANGE
Cash From Operating Activities 5.400M
Cash From Investing Activities -74.00M
Cash From Financing Activities -8.200M
Net Change In Cash -76.80M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $5.400M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q2 us-gaap Common Stock Value
CommonStockValue
251000 USD
CY2010Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
9286000 USD
CY2011Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
8725000 USD
CY2010Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
-7000 USD
CY2011Q2 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
4709000 USD
CY2011Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180300000 USD
CY2010Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
177275000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2478000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-8000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
995000 USD
CY2010Q4 us-gaap Assets
Assets
599559000 USD
CY2011Q2 us-gaap Assets
Assets
595802000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74233000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3454000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-70779000 USD
CY2011Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2010Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.32
CY2011Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.32
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.32
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2011Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25061072 shares
CY2011Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25138248 shares
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25061072 shares
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25138248 shares
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
251000 USD
CY2011Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
26300000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
26300000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12377000 USD
CY2011Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6290000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
-8051000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2011Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2923000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5592000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
485000 USD
us-gaap Increase Decrease In Deferred Rent Receivables
IncreaseDecreaseInDeferredRentReceivables
128000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-219000 USD
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
1825000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
15103000 USD
CY2011Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
7505000 USD
us-gaap Interest Paid
InterestPaid
14476000 USD
CY2010Q4 us-gaap Liabilities
Liabilities
422026000 USD
CY2011Q2 us-gaap Liabilities
Liabilities
419960000 USD
CY2011Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
595802000 USD
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
599559000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9273000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-79434000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17928000 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
2087000 USD
us-gaap Net Income Loss
NetIncomeLoss
3335000 USD
CY2011Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
18628000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
36190000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
8051000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
270000 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
86000 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
5348000 USD
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
74000000 USD
CY2010Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2010Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2010Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2010Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2010Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
547000 USD
CY2010Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
88701 USD
CY2011Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
101067 USD
CY2011Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
542590000 USD
CY2010Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
482297000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1499000 USD
CY2011Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5524000 USD
CY2010Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4716000 USD
us-gaap Revenues
Revenues
36407000 USD
CY2011Q2 us-gaap Revenues
Revenues
18805000 USD
CY2011Q2 us-gaap Secured Debt
SecuredDebt
159935000 USD
CY2010Q4 us-gaap Secured Debt
SecuredDebt
161440000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2478000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
547000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
177533000 USD
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
175842000 USD
CY2010Q4 us-gaap Unsecured Debt
UnsecuredDebt
225000000 USD
CY2011Q2 us-gaap Unsecured Debt
UnsecuredDebt
225000000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25210575 shares
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25226179 shares
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25154284 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25140781 shares
CY2011Q2 sbra Interest Income
InterestIncome
177000 USD
sbra Interest Income
InterestIncome
217000 USD
CY2011Q2 sbra Liability For Uncertain Tax Positions
LiabilityForUncertainTaxPositions
26300000 USD
CY2010Q4 sbra Liability For Uncertain Tax Positions
LiabilityForUncertainTaxPositions
26300000 USD
CY2010Q4 sbra Prepaid Expenses Deferred Financing Costs And Other Assets
PrepaidExpensesDeferredFinancingCostsAndOtherAssets
12013000 USD
CY2011Q2 sbra Prepaid Expenses Deferred Financing Costs And Other Assets
PrepaidExpensesDeferredFinancingCostsAndOtherAssets
17934000 USD
CY2011Q2 sbra Total Expenses
TotalExpenses
16718000 USD
sbra Total Expenses
TotalExpenses
33072000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
dei Document Period End Date
DocumentPeriodEndDate
2011-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001492298
CY2011Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36868248 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Sabra Health Care REIT, Inc.

Files In Submission

Name View Source Status
0001492298-11-000004-index-headers.html Edgar Link pending
0001492298-11-000004-index.html Edgar Link pending
0001492298-11-000004.txt Edgar Link pending
0001492298-11-000004-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbra-20110629.xml Edgar Link completed
sbra-20110629.xsd Edgar Link pending
sbra-20110629_cal.xml Edgar Link unprocessable
sbra-20110629_def.xml Edgar Link unprocessable
sbra-20110629_lab.xml Edgar Link unprocessable
sbra-20110629_pre.xml Edgar Link unprocessable
sbra10q63011.htm Edgar Link pending
sbraex12163011.htm Edgar Link pending
sbraex31163011.htm Edgar Link pending
sbraex31263011.htm Edgar Link pending
sbraex32163011.htm Edgar Link pending
sbraex32263011.htm Edgar Link pending
Show.js Edgar Link pending